Delivery Order SPE2DB22D1106-SPE2DB25FFHR8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,838.68 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Valtoco 10 mg nasal sprays. This firm fixed price contract, which has no set-aside designation, represents a competitive award to the pharmaceutical distributor and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 24, 2025. This contract represents a firm fixed price, non-set-aside competitive award issued on July 23, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,206.57 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Valtoco 10 mg nasal sprays. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of September 3, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a routine pharmaceutical procurement...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $5,961.54 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Valtoco 10 mg nasal sprays. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $4,618.27 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Valtoco 10 mg nasal sprays. This firm fixed price, non-set-aside contract was delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. The delivery order represents a standard pharmaceutical procurement mechanism under the federal medical supply chain. This award is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $2,551.20 and ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $3,918.84 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract represents a competitive award for pharmaceutical supplies to support federal medical procurement needs. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $2,114.78 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Valtoco 15 mg nasal sprays. The contract employs firm fixed-price pricing and is scheduled for completion by August 15, 2025. This non-competitive delivery order will be fulfilled from the company's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $1,166.08. This firm fixed price delivery order represents a non-competitive set-aside award and is scheduled for completion by July 31, 2025. The award was performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHR8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,074.07 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Valtoco 10 mg nasal sprays. This is a firm fixed-price, non-set-aside contract with a completion deadline of September 10, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp fulfills this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This delivery order represents a routine pharmaceutical supply transaction within AmerisourceBergen Drug Corp's broader federal contract portfolio with the Defense Logistics Agency. The company's established IDC with DLA enables it to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The contractor's demonstrated capability to meet federal procurement requirements through competitive award processes and its status as a primary pharmaceutical vendor position it to efficiently deliver this neurological medication to support Defense Health Agency and other military healthcare system needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/9/25 |